Showing 2591-2600 of 4063 results for "".
- 'Love Your Eyes' Confirmed as the Theme for World Sight Day 2022https://modernod.com/news/love-your-eyes-confirmed-as-the-theme-for-world-sight-day-2022/2480763/The International Agency for the Prevention of Blindness (IAPB) has confirmed it will continue the theme of #LoveYourEyes for World Sight Day 2022. World Sight Day 2021 saw over 3.5 million eye test pledges made by individuals, eye care professionals, hospitals, NGOs and businesses. Thi
- Recipients of the 2022 Prevent Blindness Jenny Pomeroy Award for Excellence in Vision and Public Health, and Rising Visionary Award Announcedhttps://modernod.com/news/recipients-of-the-2022-prevent-blindness-jenny-pomeroy-award-for-excellence-in-vision-and-public-health-and-rising-visionary-award-announced/2480762/Prevent Blindness has announced the recipient of the 2022 Jenny Pomeroy Award for Excellence in Vision and Public Health as VOSH/International (V/I). Additionally, Prevent Blindness has announced the co-recipients of the third annual “Rising Visionary Award” as Marissa K. Sh
- iSTAR Medical Announces First MINIject Surgeries Performed in the UKhttps://modernod.com/news/istar-medical-announces-first-miniject-surgeries-performed-in-the-uk/2480727/iSTAR Medical announced that it has further expanded its commercial rollout for MINIject to the UK. MINIject is iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) implant and currently the only commercially available supraciliary MIGS device. With this market exp
- Show Organizers Announce that Vision Expo+, a Complimentary, Virtual Extension of the Vision Expo Experience Will be Offered April 1–8, 2022https://modernod.com/news/show-organizers-announce-that-vision-expo-a-complimentary-virtual-extension-of-the-vision-expo-experience-will-be-offered-april-1-8-2022/2480715/The Vision Council and RX, co-organizers of Vision Expo, announced that Vision Expo+, a complimentary digital extension of the Vision Expo experience, will be offered from Friday April 1 to Friday, April 8, 2022. Vision Expo+ will be delivered through
- RG6501 (OpRegen) Full Phase 1/2a Results to Be Presented at ARVO Annual Meetinghttps://modernod.com/news/rg6501-opregen-full-phase-12a-results-to-be-presented-at-arvo-annual-meeting/2480697/Lineage Cell Therapeutics announced that full results from a phase 1/2a clinical study of RG6501 (OpRegen), a retinal pigment epithelium cell transplant therapy currently in development for the treatment of dry age-related macular degeneration (AMD), will be presented at the 2022 Associ
- SECO International and National Academy of Opticianry Expand Partnership to Bring Optician-Focused Education to SECO 2023https://modernod.com/news/seco-international-and-national-academy-of-opticianry-expand-partnership-to-bring-optician-focused-education-to-seco-2023/2480695/SECO International announced that it has expanded a partnership with the National Academy of Opticianry (NAO) to bring a dedicated educational track for opticians to SECO 2023. The NAO, founded in 1963, represents opticians worldwide and is dedicated solely to education and training of all o
- SECO Announces Its 2022 Award Winnershttps://modernod.com/news/seco-announces-its-2022-award-winners/2480691/SECO International announced the recipients of its 2022 awards. The awards recognize leaders in optometry and their significant contributions to the profession. “It is an honor and privilege to recognize this outstanding group of leaders and their contribution to the pr
- EyePoint Pharmaceuticals Appoints Isabelle Lefebvre as Chief Regulatory Officerhttps://modernod.com/news/eyepoint-pharmaceuticals-appoints-isabelle-lefebvre-as-chief-regulatory-officer/2480678/EyePoint Pharmaceuticals announced the appointment of Isabelle Lefebvre as Chief Regulatory Officer. Ms. Lefebvre brings more than 30 years of global regulatory affairs experience across all phases of drug development, including ophthalmic and ocular conditions. Ms. Lefebvre is su
- Nicox Granted Patent for NCX 470 in China, Extending Coverage to 2039https://modernod.com/news/nicox-granted-patent-for-ncx-470-in-china-extending-coverage-to-2039/2480655/Nicox SA announced that the Chinese National Intellectual Property Administration (CNIPA) has granted the company a formulation patent for NCX 470, its lead product candidate in development for patients with open-angle glaucoma or ocular hypertension, extending coverage in China to 2039. Wit
- Clearside Biomedical’s Suprachoroidal Injection Platform Featured at the Angiogenesis, Exudation, and Degeneration 2022 Virtual Conferencehttps://modernod.com/news/clearside-biomedicals-suprachoroidal-injection-platform-featured-at-the-angiogenesis-exudation-and-degeneration-2022-virtual-conference/2480642/Clearside Biomedical announced that multiple oral presentations on Clearside’s SCS injection platform featuring the SCS Microinjector were given at the Bascom Palmer Eye Institute’s Angiogenesis, Exudation, and Degeneration 2002 Virtual Event held February 11-12,